deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT04091399

First-in-man Study of Adult Patients Suffered From Alveolar Osteitis Treated Using Stomatological Tamponade Contipro

Multi-centre, Open-label, First-in-man Study of Adult Patients Suffered From Alveolar Osteitis Treated Using Stomatological Tamponade Contipro

Sponsor: Contipro Pharma a.s.

Conditions Alveolar Osteitis
Interventions Stamatological tamponade Contipro
Updated 5 times since 2019 Last updated: Sep 13, 2019 Started: Sep 11, 2015 Primary completion: Feb 12, 2016 Completion: Feb 12, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04091399, this PHASE2 trial focuses on Alveolar Osteitis and remains completed. Sponsored by Contipro Pharma a.s., it has been updated 5 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Oct 2019 – ~Jan 2021 · 15 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Oct 2019 — Jan 2021 [monthly]

    Completed PHASE2

    First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Contipro Pharma a.s.
Data source: Contipro Pharma a.s.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations